Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
SPRBSpruce Biosciences, Inc.
| Figure | SPRBSpruce Biosciences, Inc.FY2025 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | −100.0% |
| Net income | $38.97M |
| Net income, yoy | +26.5% |
| Net margin | — |
| Free cash flow | $55.96M |
| FCF margin | — |
| EPS, diluted | $50.83 |
Add another company.
Annual · FY2022–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed